Recruiting
Idiopathic pulmonary fibrosis
RecruitingEfficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
Investigational
Efficacy and Safety of Oral PIPE-791 in Adults with Idiopathic Pulmonary Fibrosis: A Phase 2 Randomized, Double‑Blind, Placebo‑Controlled Study
Investigational
- Disease:Idiopathic pulmonary fibrosis
- Substances:–
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Sponsor:Contineum Therapeutics Inc.




